Article Versions Notes

Lee NK, Myeong SH, Hwang JW, Sa JK, Son HJ, Kim HJ, Jang H, Chang JW, Na DL. Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer’s Disease. Biomedicines. 2022; 10(8):1882. https://doi.org/10.3390/biomedicines10081882

Lee, Na Kyung, Su Hyeon Myeong, Jung Won Hwang, Jason K. Sa, Hyo Jin Son, Hee Jin Kim, Hyemin Jang, Jong Wook Chang, and Duk L. Na. 2022. "Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer’s Disease" Biomedicines 10, no. 8: 1882. https://doi.org/10.3390/biomedicines10081882

Lee, N. K., Myeong, S. H., Hwang, J. W., Sa, J. K., Son, H. J., Kim, H. J., Jang, H., Chang, J. W., & Na, D. L. (2022). Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer’s Disease. Biomedicines, 10(8), 1882. https://doi.org/10.3390/biomedicines10081882